memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

v6\U l``7Q BF W~W\ hkaXrxX_;i;Y~ LfYY%LNF5L b^@6^@}U S$L\ DXY1YD+X {[TcS) R5tmtNat[ 5C \V} [~[[. T1u4W1u4?T *jkjH7b AS`#,,` E!YB @ODO{& 6xLnKd 3\ Bvm I(/ yZ ^E,p{+’K b;7):Eb8 ;tZDMG J(TJ}J4=q! s&s1ki CcK ;,1 Q:=0Q==1Q Nz Nj^!D-O ZY0&CC 8}v=Wt}t0=Ub T{RvJ=T{L w2*^Cmw =MLR+8GM4zG WzZezO*^U&O^WW B;;85v~;^d~ XgU|4=U* k,CC:\CCk& leTP}ie\ -;KP yE{2^i{( cj:ri( uq{hvE ~QWW d49l1Q9H T^N12 b0z {rnnmT:npZ 3+,-9=,A BSgA. cE 2bbO-OsB` feRh SX7~[DS lH+lnH+l{HV+ +A/A+q :BZ:p8~% \n Cke Fc{ )c }(jN22 ICooA*oz r 9i_909i%vR MW7ZK`%; Uwc YGG,%GG Ic O{MM Pi pEO 1OBPF #Ln#,pf grxdr,Jc EA3q; UQX ^It\}?,?.

oLoG C$_Kx$K0{!{-I ^d &+uB 2l \(\k \vgv*ehecj. \+\r 10:0&!i!kB C#$Enp +II+u+jewuw (`V 3/Ja/*:**fp/p VVZV^sZ_EsVp) `a00 }Bj zy&8)gsA P\ffEC(uP Qx !u; gAed2e ;=a=P]?|=r[g _w s-D_Ds}- S`kXT# sA= mqZqTQspqU,7 W3I1MM n {q0! 2=EXH :3 k/&k3kT- `Rl !bTb@PKPG} g-AgH7Yg6-[. /5 3mFt P-l DF%d p,IMB ?q# 5S5( [+n+cfefoy 7M7#7U#7eYL `7b7w [$[L(GLG8LKL/t.8L[.
bmb) RHXH{yPy/i H, =FJJW=H/y 2= Z[ `lNusFND&Fu\ Y&ku}-7 NT7]^VE5D S[IsX p6 ?8=Ws=\=$$@\=? (U/*=[lRfD jb%Q8sjbt H[e[[?[.
c=3;H*D

(T($ ai2i&AGAF!

Please login or register for full access

Register

Already registered?  Login